Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Minireviews
    • JVI Classic Spotlights
    • Archive
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JVI
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Journal of Virology
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Minireviews
    • JVI Classic Spotlights
    • Archive
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JVI
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Genetic Diversity and Evolution

Antigenic Drift Defines a New D4 Subgenotype of Measles Virus

Miguel Ángel Muñoz-Alía, Claude P. Muller, Stephen J. Russell
Douglas S. Lyles, Editor
Miguel Ángel Muñoz-Alía
aDepartment of Molecular Medicine, Mayo Clinic, Rochester, Minnesota, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Miguel Ángel Muñoz-Alía
Claude P. Muller
cDepartment of Infection and Immunity, Luxembourg Institute of Health, Esch-Sur-Alzette, Luxembourg
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stephen J. Russell
aDepartment of Molecular Medicine, Mayo Clinic, Rochester, Minnesota, USA
bDivision of Hematology, Mayo Clinic, Rochester, Minnesota, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Douglas S. Lyles
Wake Forest University
Roles: Editor
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/JVI.00209-17
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • FIG 1
    • Open in new tab
    • Download powerpoint
    FIG 1

    Neutralization activity of a panel of anti-MeV-H MAbs against 2 genotype D4 viruses. (A, top) Diagram of the MeV-H homodimeric structure. (Bottom) Radiographic crystallographic structure of the MeV-H globular head showing the location of the 6 antigenic sites. Antigenic sites are color-coded (orange, Ia; green, Ib or NE; wheat, IIa; blue, IIb; red, III; yellow, noose), indicating a representative antibody target. The signaling lymphocytic activation molecule immunoglobulin V domain and modeled N-linked sugars are shown as cyan ribbons and pink spheres, respectively. A side view is shown, as indicated at the top. The N416-linked sugar present in genotype D4 is highlighted. (B) Virus neutralization assay. Recombinant measles virus expressing 2 different MeV-H genotype D4 sequences or genotype A (vaccine strain) was incubated in the absence or presence of the indicated neutralizing antibody for 1 h at 37°C. Two days later, the numbers of enhanced green fluorescent protein-expressing foci in the presence and absence of MAbs were counted and compared. Neutralization is plotted as a percentage of the control for residual infection (y axis) by MAb concentration (x axis). For a given MAb-virus pair, the data represent the geometric means of results from at least 2 independent experiments performed in quadruplicate. NE, neutralizing epitope.

  • FIG 2
    • Open in new tab
    • Download powerpoint
    FIG 2

    Phylogenetic relationships of the MeV-N gene (left) and MeV-H gene (right) of measles virus genotype D4. The evolutionary history was inferred by using the maximum likelihood method based on the general time-reversible model. Measles virus genotype A (MVi/Maryland.USA/0.54) was used for rooting the tree. Evolutionary analyses were conducted with MEGA 6.06. Statistical support for grouping is shown as bootstrap values (1,000 replicated). Values of >80% are indicated at the deep node. The bar represents the genetic distance. The subgenotype classification is illustrated. Sequences were retrieved from the National Center for Biotechnology Information (NCBI) GenBank database and are named according to World Health Organization guidelines (Table 1).

  • FIG 3
    • Open in new tab
    • Download powerpoint
    FIG 3

    Sequence alignment of the MeV-H genes of genotype D4 viruses. The GenBank accession numbers for the MeV-H gene sequences used in the sequence alignment are shown in Table 1.

  • FIG 4
    • Open in new tab
    • Download powerpoint
    FIG 4

    Leu249Pro amino acid change as the driver mutation for escape of MeV subgenotype D4.2. (A) Neutralization activity of the NE-targeting antibodies against MeV genotypes. The neutralization assay was performed and data are represented as indicated in the legend of Fig. 1. Of note, only genotype D6 and the so-called subgenotype D4.2 viruses escape neutralization by all 3 antibodies. (B) Sequence alignment (amino acids 235 to 255) of MeV-H proteins among the MeV genotypes used in this study. (C) Effect of amino acid mutations on NE-targeting antibody neutralization. (D) NE-targeting antibody binding to MeV-H proteins. MAb binding was determined by an enzyme-linked immunosorbent assay after the addition of a nonsaturating concentration of MAbs to microtiter plates coated with the FLAG-tagged MeV-H protein. The amount of anti-FLAG antibody binding was used as a loading control. Binding values were normalized to those obtained with MeV-H genotype A. Means and standard deviations for a representative experiment performed in duplicate are shown.

  • FIG 5
    • Open in new tab
    • Download powerpoint
    FIG 5

    Neutralization of MeV by anti-MeV-H antibodies from pooled human sera. (A) Reactivity of pooled human sera after 0 days (untreated) or 4 days (MeV-F absorbed) of incubation at 37°C with cells expressing MeV-F. Binding reactivity was measured by fluorescence-activated cell sorter analysis using MeL-JuSo cells expressing or not expressing the MeV glycoproteins (MeV-H and MeV-F). Anti-human immunoglobulin G(H+L) Alexa Fluor-488 was used for staining. (B) Neutralization of MeV by anti-H pooled human sera. The IC50s and standard deviations (StDev) were calculated from 3 experiments performed independently in quadruplicate. Values were calculated after nonlinear regression of the corresponding neutralization curves with GraphPad Prism software. CDV, canine distemper virus; NA, not applicable.

Tables

  • Figures
  • TABLE 1

    List of MeV sequences used in the course of this work

    GenotypeWHO strain designationMaterialGenBank accession no.Reference
    MeV-NMeV-H
    AMVi/Maryland.USA/0.54Cell culture U01987 U03669 80
    D4MVi/Montreal.CAN/08.89Cell culture U01976 AF079554 80
    D4MVi/Montreal.CAN/12.89Cell culture AF410990 AF410975 81
    D4MVi/Montreal.CAN/25.89Cell culture AF410991 AF410976 81
    D4MVs/Brighton.GBR/49.11Cell culture KT732227 KT732227 82
    D4MVs/London.GBR/20.12Oral fluid KT732229 KT732229 82
    D4MVs/London.GBR/20.11/2Oral fluid KT732226 KT732226 82
    D4MVs/London.GBR/19.11/5Oral fluid KT732225 KT732225 82
    D4MVi/Treviso.ITA/03.10/1Cell culture (urine) KC164757.1 KC164757.1 E. Franchin et al.a
    D4MVi/New York/26.09/3Not specified JN635402.1 JN635402.1 E. F. Kirkness et al.b
    D4MVi/Florida.USA/19.09Not specified JN635403.1 JN635403.1 E. F. Kirkness et al.b
    D4MVi/Central.KEN/23.02Not specified AY249250 AY249260 46
    D4MVi/Nairobi.KEN/23.02Not specified AY249251 AY249261 46
    D4MVs/Coast-Kilifi.KEN/24.02Not specified AY249252 AY249262 46
    D4MVs/Central.KEN/24.02Not specified AY249253 AY249263 46
    D4MVs/Nyanza.KEN/24.02/1Not specified AY249254 AY249264 46
    D4MVs/Nyanza.KEN/24.02/2Not specified AY249259 AY249269 46
    D4MVi/Coast-Kwale.KEN/31.02/1Not specified AY249255 AY249265 46
    D4MVs/Eastern.KEN/35.02Not specified AY249257 AY249267 46
    D4MVi/Coast-Malindi.KEN/26.02Not specified AY249258 AY249268 46
    D4MVs/Zagreb.CRO/30.06 (SSPE)Brain tissue FJ475060.1 JX126962.1 83
    D4MVs/Bedelle.ETH/5.99Oral fluid AF280800 AF280805 84
    D4MVs/AddisAbaba.ETH/2.99Oral fluid AF280802 AF280807 84
    D4MVs/Ontario.CAN/3.15/Urine KU218405.1 KU218406.1 J. Hiebert
    D4MVs/Saint-Jean-de-Maurienne.FRA/24.09Oral fluid KJ183791.1 KJ183852.1 J. Dina
    D4MVs/Suresnes.FRA/20.10Oral fluid KJ183846.1 KJ183910.1 J. Dina
    D4MVs/Saint-Etienne.FRA/19.10Oral fluid KJ183840.1 KJ183904.1 J. Dina
    D4MVs/Limoges.FRA/18.10Oral fluid KJ183838.1 KJ183902.1 J. Dina
    D4MVs/Douai.FRA/18.10Oral fluid KJ183837.1 KJ183901.1 J. Dina
    D4MVs/Ajaccio.FRA/18.10Oral fluid KJ183836.1 KJ183900.1 J. Dina
    D4MVs/Rabastens.FRA/16.10Oral fluid KJ183833.1 KJ183896.1 J. Dina
    D4MVs/Dax.FRA/17.10Oral fluid KJ183834.1 KJ183898.1 J. Dina
    D4MVs/Bordeaux.FRA/16.10Oral fluid KJ183831.1 KJ183894.1 J. Dina
    D4MVs/Tours.FRA/13.10Oral fluid KJ183821.1 KJ183882.1 J. Dina
    D4MVs/Nantes.FRA/25.09Oral fluid KJ183795.1 KJ183856.1 J. Dina
    D4MVs/Flers.FRA/31.09/Oral fluid KJ183818.1 KJ183879.1 J. Dina
    D4MVs/Vichy.FRA/31.09/Oral fluid KJ183819.1 KJ183880.1 J. Dina
    D4MVs/Clermont-Ferrand.FRA/13.10Oral Fluid KJ183824.1 KJ183885.1 J. Dina
    D4MVs/Tarbes.FRA/30.09Oral fluid KJ183813.1 KJ183874.1 J. Dina
    D4MVs/Vannes.FRA/14.10Oral fluid KJ183826.1 KJ183887.1 J. Dina
    D4MVi/Barcelona.SPA/26.08Cell culture KY524301 KY524302 This work
    D4MVi/Madrid.SPA/10.10/1Cell culture (urine) KY524303 KY524304 This work
    • ↵a E. Franchin, F. Dal Bello, M. Pacenti, R. Cusinato, E. Lavezzo, L. Barzon, G. Palu.

    • ↵b E. F. Kirkness, R. Halpin, J. Bera, N. Fedorova, L. Overton, T. Stockwell, P. Amedeo, B. Bishop, H. Chen, P. Edworthy, N. Gupta, D. Katzel, K. Li, S. Schobel, S. Shrivastava, V. Thovarai, S. Wang, B. Bankamp, L. Byrd, W. Bellini, P. Rota.

  • TABLE 2

    Selected sites in the MeV-H genea

    Amino acidDetection of site by method
    SLACFELIFELMEME
    Positively selected sites
        Glu85Glnb •
        Leu172Metb •
        Val562Phe/Alab •
        Gln575Lysb •
    Negatively selected sites
        3Pro•••
        113Asn•••
        173Glu •
        174Ala ••
        256Glu•••
        342Asp•••
        347Asp•••
        393Leu •
        405Asn •
        445Lys •
        497Pro ••
        522Leu •
        572Thr ••
        606Cys •
        610Arg ••
    • ↵a Abbreviations: FEL, fixed-effects likelihood; IFEL, internal fixed-effects likelihood; MeV-H, measles virus hemagglutinin; MEME, mixed-effects model of episodic diversifying selection; SLAC, single-likelihood ancestor counting.

    • ↵b P value of <0.10.

PreviousNext
Back to top
Download PDF
Citation Tools
Antigenic Drift Defines a New D4 Subgenotype of Measles Virus
Miguel Ángel Muñoz-Alía, Claude P. Muller, Stephen J. Russell
Journal of Virology May 2017, 91 (11) e00209-17; DOI: 10.1128/JVI.00209-17

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Journal of Virology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Antigenic Drift Defines a New D4 Subgenotype of Measles Virus
(Your Name) has forwarded a page to you from Journal of Virology
(Your Name) thought you would be interested in this article in Journal of Virology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Antigenic Drift Defines a New D4 Subgenotype of Measles Virus
Miguel Ángel Muñoz-Alía, Claude P. Muller, Stephen J. Russell
Journal of Virology May 2017, 91 (11) e00209-17; DOI: 10.1128/JVI.00209-17
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • INTRODUCTION
    • RESULTS
    • DISCUSSION
    • MATERIALS AND METHODS
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

antigenic variation
epitopes
Hemagglutinins, Viral
measles virus
virus evolution
antibody-mediated neutralization
antigenic variation
measles virus hemagglutinin
viral epitopes
measles virus genotypes
immune evasion

Related Articles

Cited By...

About

  • About JVI
  • Editor in Chief
  • Editorial Board
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Ethics
  • Contact Us

Follow #Jvirology

@ASMicrobiology

       

 

JVI in collaboration with

American Society for Virology

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0022-538X; Online ISSN: 1098-5514